Analysis of Biologic Signatures in Crohn's Patients Undergoing Surgery

Weill Medical College of Cornell University11 enrolled

Overview

The purpose of this study is to compare the effect of two procedures - the Kono-S procedure and the side-to-side functional end to end anastomosis - on the microbiome (the bacteria that live in our gut) and on the intestinal immune system. The investigators are hypothesizing that there are differences in the microbiome environment and the immune environment between the two procedural groups.

These are two are different ways to re-connect the intestines after a portion of it is removed during surgery. Patients will be randomly assigned to either be re-connected with a procedure called the Kono-S anastomosis or with a side-to-side anastomosis during their surgery. This study will look at the microbiome and immune environment in the piece of intestine that is removed during surgery. Then, at the follow colonoscopies (3-6 month, 12-18 month, 60 month), biopsies (small pieces of tissue) will be taken near the connection between the small intestine and colon. This will be used to see how the microbiome and immune system in that area changed since the surgery. Genetic tests will be used to measure the microbiome and the levels of immune proteins in the intestines.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

OTHER

Masking

NONE

Enrollment

Conditions

Crohn Disease

Interventions

Kono-S anastomosis (KSa)PROCEDURE

antimesenteric functional end-to-end handsewn anastomosis connecting small intestine and colon after surgery

Side-to-side anastomosis (SSa)PROCEDURE

side-to-side anastomosis connecting small intestine and colon after surgery

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Patients with Crohn's ileitis/ileocolitis requiring surgical resection OR patients previously enrolled in the "Kono-S anastomosis versus side-to-side functional end anastomosis in the prevention of post-operative recurrence of Crohn's Disease (WC IRB #1303013645)" trial. 2. Patients age 18 years and older. 3. All phenotypes will be included: nonstricturing nonpenetrating (B1), stricturing (B2), and penetrating (B3) according to the Vienna classification. 4. Patients will be included regardless of preoperative medications (untreated, steroids, biologics) Exclusion Criteria: 1. Patients under 18 years of age. 2. Pregnant patients. 3. Patient does not speak English 4. Patients that may need a different surgical procedure as per the surgeon at the time of intraoperative evaluation

Locations (1)

Weill Cornell Medical Center

New York, New York, United States

Outcomes

Primary Outcomes

Changes in composition of the microbiome between treatment groups

Microbiome composition will be measured via an analysis of of 16S rRNA sequencing from tissue samples.

Time frame: At the time of the surgery

Changes in the immune cell environment between treatment groups

Immune cell environment in the tissue will be measured by gene expression levels in the tissue sample via bulk RNA sequencing.

Time frame: 3-6 month, 12-18 month and 60 month post-surgery endoscopy.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.